Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Here's a quick thought

As stated, I'm not a proponent of an R/S, just floating a possible scenario where it could be OK. I hope all works without one. I think post settlement/ruling and pre M/A we need a share price above $3 to $5 to attract institutional buyers, and open M/A financing options. I don't think $1 to $2 pps will prove a beneficial environment to the shareholders for M/A activity as it will cause additional dilution and/or inferior financing options. Buying with all cash may be an option, but what that would do to reserves and ongoing operations will be paramount.

Share
New Message
Please login to post a reply